Methylphenidate on cognitive improvement in patients with traumatic brain injury

A meta-analysis

Chi Hsien Huang, Chia Chen Huang, Cheuk Kwan Sun, Gong Hong Lin, Wen Hsuan Hou

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Although methylphenidate has been used as a neurostimulant to treat patients with attention deficit hyperactivity disorder, its therapeutic role in the psychomotor or cognitive recovery of patients with traumatic brain injuries (TBIs) in both intensive care and rehabilitation settings has not been adequately explored. To address this issue, this meta-analysis searched the available electronic databases using the key words “methylphenidate”, “brain injuries”, “head injuries”, and “traumatic brain injury”. Analysis of the ten double-blind RCTs demonstrated significant benefit in using methylphenidate for enhancing vigilance-associated attention (i.e., selective, sustained, and divided attention) in patients with TBIs (standardized mean difference: 0.45, 95% CI: 0.10 to 0.79), especially in sustained attention (standardized mean difference: 0.66, 95% CI: 0.22 to 1.10). However, no significant positive impact was noted on the facilitation of memory or processing speed. More studies on the efficacy and safety of methylphenidate for the cognitive improvement of patients with TBIs are warranted.

Original languageEnglish
Pages (from-to)272-281
Number of pages10
JournalCurrent Neuropharmacology
Volume14
Issue number3
Publication statusPublished - Apr 1 2016

Fingerprint

Methylphenidate
Meta-Analysis
Attention Deficit Disorder with Hyperactivity
Critical Care
Craniocerebral Trauma
Brain Injuries
Rehabilitation
Databases
Safety
Traumatic Brain Injury
Therapeutics

Keywords

  • Attention
  • Cognitive function
  • Methylphenidate
  • Traumatic brain injury

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Pharmacology
  • Neurology
  • Psychiatry and Mental health

Cite this

Methylphenidate on cognitive improvement in patients with traumatic brain injury : A meta-analysis. / Huang, Chi Hsien; Huang, Chia Chen; Sun, Cheuk Kwan; Lin, Gong Hong; Hou, Wen Hsuan.

In: Current Neuropharmacology, Vol. 14, No. 3, 01.04.2016, p. 272-281.

Research output: Contribution to journalArticle

Huang, Chi Hsien ; Huang, Chia Chen ; Sun, Cheuk Kwan ; Lin, Gong Hong ; Hou, Wen Hsuan. / Methylphenidate on cognitive improvement in patients with traumatic brain injury : A meta-analysis. In: Current Neuropharmacology. 2016 ; Vol. 14, No. 3. pp. 272-281.
@article{4c1a2ced4ef547c4af476ebd8ed1699a,
title = "Methylphenidate on cognitive improvement in patients with traumatic brain injury: A meta-analysis",
abstract = "Although methylphenidate has been used as a neurostimulant to treat patients with attention deficit hyperactivity disorder, its therapeutic role in the psychomotor or cognitive recovery of patients with traumatic brain injuries (TBIs) in both intensive care and rehabilitation settings has not been adequately explored. To address this issue, this meta-analysis searched the available electronic databases using the key words “methylphenidate”, “brain injuries”, “head injuries”, and “traumatic brain injury”. Analysis of the ten double-blind RCTs demonstrated significant benefit in using methylphenidate for enhancing vigilance-associated attention (i.e., selective, sustained, and divided attention) in patients with TBIs (standardized mean difference: 0.45, 95{\%} CI: 0.10 to 0.79), especially in sustained attention (standardized mean difference: 0.66, 95{\%} CI: 0.22 to 1.10). However, no significant positive impact was noted on the facilitation of memory or processing speed. More studies on the efficacy and safety of methylphenidate for the cognitive improvement of patients with TBIs are warranted.",
keywords = "Attention, Cognitive function, Methylphenidate, Traumatic brain injury",
author = "Huang, {Chi Hsien} and Huang, {Chia Chen} and Sun, {Cheuk Kwan} and Lin, {Gong Hong} and Hou, {Wen Hsuan}",
year = "2016",
month = "4",
day = "1",
language = "English",
volume = "14",
pages = "272--281",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - Methylphenidate on cognitive improvement in patients with traumatic brain injury

T2 - A meta-analysis

AU - Huang, Chi Hsien

AU - Huang, Chia Chen

AU - Sun, Cheuk Kwan

AU - Lin, Gong Hong

AU - Hou, Wen Hsuan

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Although methylphenidate has been used as a neurostimulant to treat patients with attention deficit hyperactivity disorder, its therapeutic role in the psychomotor or cognitive recovery of patients with traumatic brain injuries (TBIs) in both intensive care and rehabilitation settings has not been adequately explored. To address this issue, this meta-analysis searched the available electronic databases using the key words “methylphenidate”, “brain injuries”, “head injuries”, and “traumatic brain injury”. Analysis of the ten double-blind RCTs demonstrated significant benefit in using methylphenidate for enhancing vigilance-associated attention (i.e., selective, sustained, and divided attention) in patients with TBIs (standardized mean difference: 0.45, 95% CI: 0.10 to 0.79), especially in sustained attention (standardized mean difference: 0.66, 95% CI: 0.22 to 1.10). However, no significant positive impact was noted on the facilitation of memory or processing speed. More studies on the efficacy and safety of methylphenidate for the cognitive improvement of patients with TBIs are warranted.

AB - Although methylphenidate has been used as a neurostimulant to treat patients with attention deficit hyperactivity disorder, its therapeutic role in the psychomotor or cognitive recovery of patients with traumatic brain injuries (TBIs) in both intensive care and rehabilitation settings has not been adequately explored. To address this issue, this meta-analysis searched the available electronic databases using the key words “methylphenidate”, “brain injuries”, “head injuries”, and “traumatic brain injury”. Analysis of the ten double-blind RCTs demonstrated significant benefit in using methylphenidate for enhancing vigilance-associated attention (i.e., selective, sustained, and divided attention) in patients with TBIs (standardized mean difference: 0.45, 95% CI: 0.10 to 0.79), especially in sustained attention (standardized mean difference: 0.66, 95% CI: 0.22 to 1.10). However, no significant positive impact was noted on the facilitation of memory or processing speed. More studies on the efficacy and safety of methylphenidate for the cognitive improvement of patients with TBIs are warranted.

KW - Attention

KW - Cognitive function

KW - Methylphenidate

KW - Traumatic brain injury

UR - http://www.scopus.com/inward/record.url?scp=84961700346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961700346&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 272

EP - 281

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 3

ER -